2.10.2019 | Ajankohtaista
Haluamme korostaa, että gradusta saadun arvosanan EI TARVITSE olla 5 (erinomainen), jotta palkintoa voi hakea!
Suomen Solubiologit ry myöntää joka toinen vuosi parhaalle solu- ja molekyylibiologian alan pro gradu -työlle tunnustuspalkinnon. Tunnustus myönnetään innovatiiviselle ja korkeatasoiselle tutkielmalle, joka edistää alan tutkimusta.
Palkinnon arvo on 200€, ja se myönnetään marraskuussa 2019 Jyväskylän yliopistolla järjestettävässä seminaarissa. Voittajalle ilmoitetaan palkinnosta etukäteen. Pro gradu -työn tulee olla hyväksytty 1.1.2018-15.10.2019 välisenä aikana. Hakijan tulee olla Suomen Solubiologit ry:n jäsen. Palkintoa voi hakea, vaikka maisterintutkinto ei olisi vielä kokonaisuudessaan valmis. Tutkielma voi olla hyväksytty missä tahansa Suomen yliopistossa.
Lähetä pro gradusi pdf-tiedostona osoitteeseen suomensolubiologit@gmail.com viimeistään 15.10.2019. Liitä mukaan tutkielmasi arvostelulausunto sekä lyhyt (max. 1 sivun mittainen) motivaatiokirje, jossa kerrot, miksi sinun gradusi kuuluisi palkita, ja mikä on mielestäsi pro gradu -työsi merkitys solu- ja molekyylibiologian alan tutkimukselle. Lisätietoja apurahasta ja hakemisesta antavat Elina Siljamäki (elisil@utu.fi), Johanna Matilainen (johanna.matilainen@hotmail.com) sekä Jenni Tuominen (jementu@gmail.com).
1.10.2019 | Avoimet työpaikat
https://rekry.oikotie.fi/recruitment/jobs/bayer/o/41523/fi_FI/fi_FI/details
MICROBIOLOGIST
Bayer Oy
Kansainvälisen Bayerin ydinosaaminen on Life Science -alalla terveydenhoidon ja maatalouden parissa. Innovaatioyrityksenä Bayer näyttää suuntaa tutkimusintensiivisillä alueilla. Bayerin tuotteet ja palvelut on suunniteltu ihmisiä hyödyttäviksi ja elämänlaatua parantaviksi. Kansainvälinen toimintamme Suomessa keskittyy reseptilääkkeisiin: tutkimukseen ja tuotekehitykseen, tuotantoon ja useiden kansainvälisten kliinisten tutkimusten johtamiseen. Bayer työllistää Suomessa noin 850 henkilöä. Toimipaikkamme ovat Espoossa ja Turussa. Bayerilla saat työskennellä työkulttuurissa, jossa arvostetaan henkilöstön paloa luoda uraauurtavia innovaatioita ja annetaan mahdollisuus muuttaa maailmaa. Turun tuotantolaitos on osa Bayerin globaalia lääkevalmistusorganisaatiota, missä keskitymme polymeeripohjaisten lääkeannostelumenetelmien valmistukseen ja jakeluun.
Haemme nyt mikrobiologiseen laboratorioomme henkilöä äitiysvapaan sijaisuuteen arviolta heinäkuun loppuun 2020 asti
Microbiologist -tehtävään
TEHTÄVÄSI JA VASTUUALUEESI
• Osallistut laboratoriossa mikrobien tunnistusprosessien kehittämiseen.
• Osallistut muihin toiminnan kehittämisprojekteihin laatimalla selvityksiä, raportteja, ohjeita ja yhteenvetoja.
• Toimit tarvittaessa erilaisissa laboratoriotehtävissä mm. suorittamalla mikrobiologisia määrityksiä.
SINÄ
• Työssäsi selvität määrätietoisesti ja oma-aloitteisesti annettuja tehtäviä, ja olet luonteeltasi huolellinen, reippaan utelias ja rohkea selvittämään asioita. Tulet myös hyvin toimeen erilaisten ihmisten kanssa.
• Osana kansainvälistä organisaatiotamme pystyt kommunikoimaan myös englannin kielellä.
• Sinulla on tehtävään soveltuva koulutus, esim. mikrobiologin tai biokemistin tutkinto ja mielellään kokemusta tehtävistä mikrobiologisessa laboratoriossa sekä mikrobien tunnistamisesta.
• Aiemman projektiluonteisen työkokemuksen luemme eduksi.
Lisätietoja tehtävästä antaa Laboratory Manager Tuuli Virtanen, ti 1.10. klo 14.30–15.30 ja pe 4.10. klo 14–15, puh. 0400 841560.
Hae tehtävää 9.10.2019 mennessä.
#LI-NOR
| Määräaikainen työsuhde |
| Työn laatu | Kokopäiväinen |
| Sijainti | Turku, Suomi
|
| Hakuaika | 27.9.2019 – 9.10.2019 |
1.10.2019 | Avoimet työpaikat
https://careers.udel.edu/en-us/job/494300/limited-term-researcher-kinesiology-applied-physiology
https://sites.udel.edu/kaap/hudson-lab/
1.10.2019 | Avoimet työpaikat
http://www.eracareers.pt/opportunities/index.aspx?task=showAnuncioOportunities&jobId=117974&idc=1
30.9.2019 | Ajankohtaista
Suomen Solubiologit ry myöntää joka toinen vuosi parhaalle solu- ja molekyylibiologian alan pro gradu -työlle tunnustuspalkinnon. Tunnustus myönnetään innovatiiviselle ja korkeatasoiselle tutkielmalle, joka edistää alan tutkimusta.
Palkinnon arvo on 200€, ja se myönnetään marraskuussa 2019 Jyväskylän yliopistolla järjestettävässä seminaarissa. Voittajalle ilmoitetaan palkinnosta etukäteen. Pro gradu -työn tulee olla hyväksytty 1.1.2018-31.8.2019 välisenä aikana. Hakijan tulee olla Suomen Solubiologit ry:n jäsen. Palkintoa voi hakea, vaikka maisterintutkinto ei olisi vielä kokonaisuudessaan valmis. Tutkielma voi olla hyväksytty missä tahansa Suomen yliopistossa.
Lähetä pro gradusi pdf-tiedostona osoitteeseen suomensolubiologit@gmail.com viimeistään 1.10.2019. Liitä mukaan tutkielmasi arvostelulausunto sekä lyhyt (max. 1 sivun mittainen) motivaatiokirje, jossa kerrot, miksi sinun gradusi kuuluisi palkita, ja mikä on mielestäsi pro gradu -työsi merkitys solu- ja molekyylibiologian alan tutkimukselle. Lisätietoja apurahasta ja hakemisesta antavat Elina Siljamäki (elisil@utu.fi), Johanna Matilainen (johanna.matilainen@hotmail.com) sekä Jenni Tuominen (jementu@gmail.com).
26.9.2019 | Avoimet työpaikat
https://www.helsinki.fi/fi/avoimet-tyopaikat/postdoctoral-researcher-research-group-mikko-niemi
The Faculty of Medicine
promotes scientific research of a high standard and is responsible for
providing research-based undergraduate and postgraduate education in
medicine, dentistry, psychology and logope-dics, as well as for the
English-language Master’s Programme in Translational Medicine. In
addition to its teaching and research activities, the Faculty serves as a
significant expert organisation in the healthcare sector and
contributes to the discourse on ethics in the field. In terms of
research, the Faculty aims for a place among the best medical faculties
in the world, while consolidating and strengthening its status as a
top-level institution of medical education.
Together with the Helsinki University Hospital (HUS) and the Helsinki
Institute of Life Sciences (HiLIFE), the Faculty of Medicine,
University of Helsinki, constitutes the Academic Medical Center Helsinki
(AMCH). This medical center has been very successful in international
comparisons, ranking among the top 10 medical campuses in Europe and
among the top 50 globally.
Research Programs Unit (RPU) of the Faculty of Medicine, University of Helsinki (https://www.helsinki.fi/en/faculty-of-medicine/research-programs-unit)
consolidates demonstrated research excellence, with focused research
programs addressing the greatest challenges in human health. Research
programs provide the critical mass to combine biomedical, translational
and clinical research, forming a synergistic platform for top-class
scientific and translational discoveries. Nine research programs
comprise of 89 research groups in total.
The research group of Prof. Mikko Niemi at the Department of Clinical Pharmacology, is looking for a
Postdoctoral researcher
to be responsible for pharmacogenomics laboratory analyses of the IndiviStat project.
The research group of Prof. Mikko Niemi explores the effects of human
genetics on the transport and metabolism of drugs. The main focus of the
group has recently been on identifying novel genetic determinants of
drug response employing targeted massively parallel sequencing meth-ods.
Mikko Niemi’s group invites applications for a positon of Postdoctoral
researcher to work in project IndiviStat which is an ERC Consolidator
grant project aiming to individualize statin ther-apy by using a systems
pharmacology decision support algorithm.
The position is available immediately or latest at the beginning of
January 2020 until July 2022, with a possibility of extension.
Requirements:
-PhD degree in genetics or related field
-Experience in genetic laboratory analyses
-Good written and oral communication skills in English
-Ability to work independently and as a part of a multidisciplinary research group
-Experience in next-generation sequencing and bioinformatics is considered to be an ad-vantage
Salary (level 5) is based on the demands level chart for teaching and
research personnel in the salary system of Finnish universities. In
addition, a salary component based on personal work performance will be
paid. There will be a six-month trial period for the position.
The application, together with the required attachments, must be
submitted through the Universi-ty of Helsinki electronic recruitment
system by clicking on Apply for job. Internal applicants (i.e., current
employees of the University of Helsinki) must submit their applications
through the SAP HR portal. The application should include a short cover
letter describing your areas of ex-pertise and motivation for the
position, CV, and names and contact information of two references.
The dead line for applications is 8.10.2019
For further information, please contact: marja.e.masanti(at)helsinki.fi
For more information on the research group, please see
https://www.helsinki.fi/en/researchgroups/clinical-pharmacology-and-phar…
In case you need technical support with the recruitment system, please contact recruit-ment(at)helsinki.fi.
Haku päättyy
08.10.2019 23:59 EEST
26.9.2019 | Avoimet työpaikat
https://www.helsinki.fi/fi/avoimet-tyopaikat/postdoctoral-researcher-in-evolutionary-sequence-analysis
The University of Helsinki
is a leading Nordic university with a preeminent role in life science
research. Within the university, the Institute of Biotechnology (BI) is a
part of the Helsinki Institute of Life Science (HiLIFE), dedicated to
successful development of biotechnology and integrative biology and the
application of this knowledge for the benefit of society. HiLIFE
coordinates research infrastructures, provides research-based
interdisciplinary training, and supports researchers within its units
and partner faculties.
The group of Ari Löytynoja is inviting applications for a
Postdoctoral researcher in evolutionary sequence analysis
for 3 years fixed term. The full-time position will start in November 2019, or later by agreement.
Template switching is a poorly known mutational mechanism that
copies short stretches of sequence from the opposite strand and causes
clusters of differences between homologous sequences. The mechanism has
previously been studied in microbes and we recently showed (https://genome.cshlp.org/content/27/6/1039)
that mutation patterns consistent with it are polymorphic also in
humans. The role and significance of template switching in evolution of
genes and organisms is not known.
We are now looking for a dedicated and enthusiastic post-doctoral
fellow to join in a project studying this mechanism in more detail. The
applicant is required to hold PhD in evolutionary biology,
bioinformatics, computer science, or a related field, as well as strong
written and oral communication skills. The working language of the lab
is English; knowledge of the Finnish language is not necessary.
Experience in computer programming and Linux systems is required, prior
experience in evolutionary sequence analysis is an advantage. The salary
is based on level 5 of the job requirement scheme for teaching and
research personnel in the salary system of Finnish universities. In
addition, the appointee will be paid a salary component based on
personal work performance.
To apply, please submit your application using the University of
Helsinki electronic recruitment system by clicking on Apply for job.
Internal applicants must submit their applications through the SAP HR
portal. Upload a single pdf-file containing a one-page letter with a
personal statement outlining your relevant work experience and
motivation to work on this particular project; your CV and bibliography;
and contact information for 2-3 references. Review of applications will
begin immediately and will continue until the position is filled. For
informal inquiries, contact ari.loytynoja(at)helsinki.fi
Haku päättyy
15.11.2019 23:59 EET
26.9.2019 | Avoimet työpaikat
https://duunitori.fi/tyopaikat/tyo/orion-research-scientist-immuno-oncology-turku-sdsuu-11558259?utm_source=twitter&utm_medium=social&utm_campaign=loimutyopaikat
Työpaikkakuvaus
Orion Corporation is a globally operating Finnish pharmaceutical
company – a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals and active pharmaceutical
ingredients. Read more about us.
Description of the unit
Oncology
Research is accountable for the discovery of novel targets and supports
drug projects with related biology research in the therapy area of
oncology at Orion. Immuno-oncology team is one of four reseach teams in
Oncology Research, and our teams build the R&D Oncology portfolio
and Oncology strategy in close collaboration with business and all
R&D global functions. You will be based in Turku, Finland and report
to the Vice President of Oncology Research.
Main responsibilities
As
a research scientist you would be working in the IO team and in
collobaration with other functions, such as medicinal chemistry and
biologics. The work entails:
- Hands-on in in vivo and in vitro research in immuno-oncology
- target identification and validation experiments
- drug project pharmacology tests
- Development of new methodology and technologies
- Writing scientific reports and publications
We Offer
We are offering an excellent opportunity to work in a dynamic team building up Oncology Research at Orion.
In
Orion we have a highly interesting R&D pipeline and enthusiastic
working environment with opportunities to use your own strengths to
build your competence development and career. We offer exciting
opportunities to create and have an impact to the future therapies for
patients. As an expert of your own field you will be a member of
multi-disciplinary team jointly innovating and developing new treatments
for the patients. Appreciation of colleagues and continuous development
are part of our core values. The culture of Orion R&D is informal
and we enjoy working together.
Join us – together we build well-being and do work that we are proud of!
Requirements
- MSc or PhD
- Expertise in immunology
- Track record of scientific publications in the field of immunology/oncology
- Broad methodological background in immunology
- Good collaborative skills
- Industry experience is an advantage
Contact information
Please send your
application latest on October 13th 2019. For further information, please
call Prof. Outi Vaarala, VP Oncology Research, 358-50-9663472, during the following hours: September 26th at 13:30-15:30, October 2nd at 12:30-14:30 and October 9th at 13:00-15:00 (EEST).
Orion
Corporation operates in more than 25 countries, where we Orionees, 3400
in total, work in all kinds of positions. We encourage people to
develop their competences, and offer opportunities to affect own job
description and create own career path at Orion.
#LI-ORION
Approved
medical examination which also includes drug testing is required prior
to the employment. We will also carry out a security clearance prior to
the employment for the selected person.
26.9.2019 | Avoimet työpaikat
https://duunitori.fi/tyopaikat/tyo/orion-senior-research-scientist-immuno-oncology-turku-sdsuu-11558264?utm_source=twitter&utm_medium=social&utm_campaign=loimutyopaikat
Työpaikkakuvaus
Orion Corporation is a globally operating Finnish pharmaceutical
company – a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals and active pharmaceutical
ingredients. Read more about us.
Description of the unit
Oncology
Research is accountable for the discovery of novel targets and drug
projects related biology reseach in the therapy area of oncology at
Orion. Immuno-oncology team is one of four reseach teams in Oncology
Research, and our teams build the R&D Oncology portfolio and
Oncology strategy in close collaboration with business and all R&D
global functions. You will be based in Turku, Finland and report to the
Vice President of Oncology Research. You will be based in Turku, Finland
and report to the Vice President of Oncology Research.
Main responsibilities
- Identification of new drug targets and building the evidence for target validation
- Provide disease biology understanding and immunology support for the drug projects
- Development of new methodology and technologies
- Hands-on in in vivo and in vitro research in immuno-oncology
- Writing scientific reports and publications
- Contribute to the research strategy in Oncology TA
We Offer
We are offering an excellent opportunity to work in a dynamic team building up Oncology Research at Orion.
In
Orion we have a highly interesting R&D pipeline and enthusiastic
working environment with opportunities to use your own strengths to
build your competence development and career. We offer exciting
opportunities to create and have an impact to the future therapies for
patients. As an expert of your own field you will be a member of
multi-disciplinary team jointly innovating and developing new treatments
for the patients. Appreciation of colleagues and continuous development
are part of our core values. The culture of Orion R&D is informal
and we enjoy working together.
Join us – together we build well-being and do work that we are proud of!
Requirements
- PhD in immunology with at least 3 year Post doctoral experience
- Expertise in immune-oncology research
- Track record of high impact publications in the field of immunology/oncology
- Broad methodological background in immunology
- Good collaborative skills
- Industry experience is an advantage
Contact information
Please send your
application latest on October 13th 2019. For further information, please
call Prof. Outi Vaarala, VP Oncology Research, 358-50-9663472, during the following hours: September 26th at 13:30-15:30, October 2nd at 12:30-14:30 and October 9th at 13:00-15:00 (EEST).
Orion
Corporation operates in more than 25 countries, where we Orionees, 3400
in total, work in all kinds of positions. We encourage people to
develop their competences, and offer opportunities to affect own job
description and create own career path at Orion.
#LI-ORION
Approved medical examination which also includes drug testing is
required prior to the employment. We will also carry out a security
clearance prior to the employment for the selected person.
26.9.2019 | Avoimet työpaikat
https://duunitori.fi/tyopaikat/tyo/orion-team-leader-immuno-oncology-turku-sdsuu-11558204?utm_source=twitter&utm_medium=social&utm_campaign=loimutyopaikat
Työpaikkakuvaus
Orion Corporation is a globally operating Finnish pharmaceutical
company – a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals and active pharmaceutical
ingredients. Read more about us.
Description of the unit
Oncology
Research is accountable for the discovery of novel targets and drug
projects related biology reseach in the therapy area of oncology at
Orion. Immuno-oncology team is one of four reseach teams in Oncology
Research, and our teams build the R&D Oncology portfolio and
Oncology strategy in close collaboration with business and all R&D
global functions. You will be based in Turku, Finland and report to the
Vice President of Oncology Research.
Main responsibilities
- Supervise and build up the Immuno-oncology team in in vivo and in vitro research
- Ensure the resourcing and optimal plans for the drug projects from pre-clinical to clinical development
- Identification of new drug targets and building the evidence for target validation
- Development of new technologies
- Writing scientific reports and publications
- Contribute to the research strategy in Oncology TA
We offer
We offer an excellent opportunity to work in a dynamic team building up Oncology Research at Orion.
In
Orion we have a highly interesting R&D pipeline and enthusiastic
working environment with opportunities to use your own strengths to
build your competence development and career. We offer exciting
opportunities to create and have an impact to the future therapies for
patients. As an expert of your own field you will be a member of
multi-disciplinary team jointly innovating and developing new treatments
for the patients. Appreciation of colleagues and continuous development
are part of our core values. The culture of Orion R&D is informal
and we enjoy working together.
We are passionate about the
patient welfare and serve as The Voice of Science and the Patient. Join
us – together we build well-being and do work that we are proud of!
Requirements
- PhD in immunology with at least 5 year Post doctoral experience
- Expertise in immune-oncology research
- Experience as a scientific leader/supevisor
- Track record of high impat publications in the field of immunology/oncology
- Deep understanding of in vitro and in vivo cancer models
- Industry experience is an advantage
- Excellent organizational and people leadership skills
Contact information
Please send your application latest on October 13th 2019 via the ”Apply” button. For further information, please call Prof. Outi Vaarala, VP Oncology Research, 358-50-9663472, during the following hours: September 26th at 13:30-15:30, October 2nd at 12:30-14:30 and October 9th at 13:00-15:00 (EEST).
Orion
Corporation operates in more than 25 countries, where we Orionees, 3400
in total, work in all kinds of positions. We encourage people to
develop their competences, and offer opportunities to affect own job
description and create own career path at Orion.
#LI-Orion
Approved medical examination which also includes drug testing is
required prior to the employment. We will also carry out a security
clearance prior to the employment for the selected person.